Scott Rocklage is a Managing Partner of the life-science based venture capital firm, 5AM Ventures, and he has been so since 2004. He brings with him years of experience in the healthcare management industry as well as a background in science. Early on in life, Rocklage studied at the University of California, Berkeley where he earned a Bachelor’s of Science Degree in Chemistry. He went on to pursue and complete his Ph.D. in Chemistry at the Massachusetts Institute of Technology. It was there that he performed research in the lab of the Nobel Prize winner, Richard R. Schrock. Over the years, he also invented or was the co-inventor of more than 30 United States patents.
Scott Rocklage was the CEO of EPIRUS Biopharmaceuticals, Inc. and was also its Acting CEO for a period of time. He also worked with Amersham Health as its CEO and President and was the Co-President of Ilypsa, Inc. Previously, Rocklage sat as the President of Cubist Pharmaceuticals Inc. for seven years and also was its Founding Chief Executive Officer for nine years. Before this, he was the CEO and President of Nycomed Salutar, Inc. and the CEO, Chairman, and President of Nycomed Interventional, Inc. Today he sits as a part of the Board of Directors of Nouscom AG and works with MDS Proteomics, Inc. as a Director.
Scott Rocklage was the man responsible for the FDA approval of Cubicin, Omniscan, and Teslascan, and he has also worked on many other possible drug candidates. He has found that it is his skills of organization, prioritizing, and time management that have helped him to become the success he is. He has also learned that a company does its best when it focuses, heavily, on the selection of its team. This is where he says many business leaders get jammed up, and this has caused him problems in the past. It was when he learned to stop staying stuck on a bad employee hire that he found that his businesses would run more smoothly. He has expressed that it doesn’t matter what you do to try to motivate or change an employee that is not the right fit for your company. If they have a set of underlying deficiencies that cause them to do poorly, it’s best to not waste a lot of time trying to make them change. Instead, it’s best to move forward and focus on the rest of your team and work to find a better fit for your company.
Visit http://5amventures.com/team/scott-m-rocklage-phd/ to learn more.